Author: Marie Jones

AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company’s efforts toward joining the global health community in the fight against the deadly Wuhan coronavirus that has so far infected approximately 40,000 people and killed almost one thousand, primarily in China. Coronaviruses are a large family of viruses, including the deadly Severe Acute Respiratory Syndrome (SARS). After a 2002 SARS outbreak in the Guangdong province of southern China caused more than 8,000 cases and more than 800 deaths, the United States’ National Institutes of Health contracted studies…

BH Global Corporation Limited (“BH Global”), is pleased to announce that BOS Offshore & Marine Pte Ltd (“BOS”), a 90% owned subsidiary of the Group, has entered into a Memorandum of Understanding (“MoU”) with strategic project partners Penguin International Limited (“Penguin International”), Danfoss, Durapower Technology (Singapore) Pte Ltd (“Durapower”) and Bureau Vitas Marine (Singapore) Pte Ltd (“BV”) for the joint design, development and construction of Singapore’s first plug-in hybrid electric fast launch. The scope of cooperation includes integrating hybrid electric solutions, testing and certification. The know-how generated will support Singapore’s push towards the adoption of hybrid electric propulsion systems for…

Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications. This new research collaboration has the potential to deliver much-needed plant health and nutrition improvements to food crops so farmers can more efficiently and sustainably grow improved plant varieties that deliver the types of foods consumers want. “Farmers need innovative solutions as they face limited natural resources and a changing climate,” said Jeremy Williams, Head of Plant Biotechnology, Crop Science Research & Development…

Maybank Indonesia has announced the date for its ninth Maybank Marathon event in Bali, an annual international road race event to be held on August 30, 2020. Registration starts on Feb 25 at 12:00 WIB . Categories of competition are marathon (42.195 km), half-marathon (21.0975 km), 10K and kids dash. This year’s Maybank Marathon has been designated a World Athletics ‘Bronze Label’ Road Race, and becomes the first marathon in Indonesia to have achieved this prestigious label. The ‘Bronze Label’ is only awarded to a marathon event that fulfills all international requirements and regulations and has been verified by World…

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in relation to its repurposed drug candidate, SACT-1, for the treatment of neuroblastoma, a rare type of childhood cancer that develops in infants and young children. Subject to completion of current validation studies, Aptorum Group plans to leverage the 505(b)(2) pathway and submit an IND submission with the FDA for SACT-1 in H2 2020.1 SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACTTM drug discovery platform, which employs…

TANAKA HOLDINGS Co., Ltd. (Head office: Chiyoda-ku, Tokyo; Representative Director and CEO: Akira Tanae) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2020 (a total of 12 medals). The Tokyo Marathon 2020 is organized by the Tokyo Marathon Foundation, and will be held on March 1, 2020; the wheelchair marathon has been an officially sanctioned as an international event since 2016. The Tokyo Marathon medals provided by TANAKA HOLDINGS are made from pure gold, pure silver, and pure bronze -…

The outbreak of coronavirus which began in China now threatens people around the world. While it is unknown how the virus is transmitted and as no treatment has been found, the World Health Organization (WHO) declared the outbreak a Public Health Emergency of International Concern (PHEIC). A coordinated international response is required to mitigate it. “The coronavirus epidemic has become a humanitarian crisis,” said Ahyudin, Chairman of the Board of Trustees of ACT, at a press conference this week. “We have to understand that it is humanity that is afflicted. And this should become the momentum for moving the community…

Three Garden Road, one of the two landmark properties owned by Champion Real Estate Investment Trust (“Champion REIT”; stock code: 2778), has received WELL Core Certification at Platinum level under the WELL Building Standard by the International WELL Building InstituteTM (“IWBITM”), making it the first existing building in Hong Kong to score at the highest level of WELL certification. Three Garden Road has fulfilled the WELL Platinum standard, including air, water, light, nourishment, movement, thermal comfort, sound, materials, mind and community. This recognition is a testament to Champion REIT’s commitment in enhancing people’s health and environmental preservation in our properties.…

Hong Kong listed VPower Group International Holdings Limited (VPower Group), a leading DPG station owner and operator in Asia, announced today (10 February) that the Group and China National Technical Import & Export Corporation (CNTIC) have set up a joint venture company with nominal equity capacity, held as to 50% by each party, for the investment in, development and operation of three power projects in Myanmar with an aggregate contract capacity of 900MW. Established in 1952, CNTIC is wholly-owned subsidiary of China General Technology (Group) Holding Ltd. which is under direct supervision of the central government of the People’s Republic…

Amidst growing concerns of infection by the Wuhan coronavirus, Malaysians queued up today at local pharmacies to stock up on a handheld NatShield(TM) sanitizer containing an active ingredient that has been proven to be effective in combating over 170 deadly pathogens including previously known coronaviruses. Homegrown healthcare company Holista CollTech (“Holista”) said, since 29 January 2020, it had rushed out the first 5,000 bottles of the initial order of 60,000 bottles of NatShield(TM) to local pharmaceutical chains including Big Pharmacy after stocks ran out earlier in January. The next batch of 15,000 bottles is being despatched to Malaysian pharmacies this…

鉴于对武汉冠状病毒感染的担忧进一步加深，马来西亚民众今日在当地药店排队等候，购买一种含有有效成分的手持式NatShield(TM)消毒液。事实证明，该成分可有效对抗170多种致命病原体，包括先前已知的冠状病毒。 本土医疗保健企业Holista CollTech（以下简称 Holista）表示，1月初消毒剂库存清零后，自2020年1月29日起，60,000瓶NatShield(TM)的最初订单中，已有5,000瓶被加急运送到包括Big Pharmacy在内的各大药房中。 下一批15,000瓶消毒液将于本周发往马来西亚的各个药房。 该20毫升消毒剂在马来西亚药房的零售价约为25马币。每瓶NatShield(TM)消毒剂均含有5％的Path-Away(R)。Path-Away(R)是一种经美国食品药品监督管理局和马来西亚卫生部批准的植物性活性成分。它还在世界卫生组织认证的多个实验室内接受了测试。 由美国南卡罗来纳州的Global Infections Control Consultants LLC（以下简称GICC LLC）开发的Path-Away(R)可攻击微生物的细胞壁，抑制其对繁殖所需氨基酸的摄取。微生物种群聚集在一起并在此过程中自我消亡。不含酒精的Path-Away(R)对人体无害，目前正用于测试其对武汉起源的新型冠状病毒的有效性。 总部位于吉隆坡的Holista是澳大利亚的上市公司，是东盟地区Path-Away(R)的独家分销商。公司进口活性成分，然后在马来西亚的几家装瓶厂按照严格标准进行灌装。Holista将NatShield(TM)分销给三个药房连锁品牌，涵盖全马3,000多家药房。 Holista首席执行官Rajen Manicka博士在八打灵再也Bigal Pharmacy的一家药店的简报会上说：”2020年1月29日库存耗尽后，我们一直在昼夜不停地安排大马的订单。到目前为止，我们已经收到42,000瓶的确认订单，其中到上周末已售出5,000瓶。” “为了满足对消毒剂需求，我们打算在2月底之前将马来西亚的出货量从最初的60,000瓶增加到145,000瓶，并包括20毫升和30毫升两种规格。我们还计划在未来几周内提供60毫升的家庭装。除马来西亚外，我们还收到了许多海外咨询。公司将在未来几周内更新有关出货量增加的信息。”他补充道。 Big Pharmacy首席执行官Lee Meng Chuan补充说：”我们正在竭尽全力满足所有71家门店的需求。客户的健康和福祉是重中之重。我们将在未来几周内与Holista紧密合作，以满足客户的需求。” Holista已确认参与国家贸易促进机构马来西亚对外贸易发展局（以下简称 MATRADE）的一项倡议，以支持武汉冠状病毒的受害者。该计划被称为”帮助武汉”行动。Holista已捐赠10,000令吉作为初期捐款，并将进一步捐赠其NatShield(TM)消毒液销售收入的2％。 拿督Rajen博士还宣布，Holista还将使用Path-Away(R)活性成分加速鼻香膏的开发，这种成分可降低感染风险。Holista计划于2020年3月之前申请自己的鼻香膏全球专利，以期在2020年第三季度前向国际消费市场投入该产品。 Path-Away(R)的成分已获得”公认安全”（以下简称GRAS）的认证，美国食品药品监督管理局（以下简称FDA）的批准，以及美国环境保护署（EPA）的豁免。它已在美国药典（USP）中列出，且作为消毒液成功通过了USP-51测试。 Path-Away(R)还获得了新西兰食品安全局和环境保护局的批准。它已被马来西亚卫生部批准使用，还特别提及了H1N1病毒。 Holista已获许可在东南亚制造和分销NatShield(TM)。 Holista CollTech Ltd简介 HolistaCollTech Ltd（以下简称”Holista”）是一家以科研为重心的生物技术公司，由Holista Biotech SdnBhd与CollTech Australia Ltd.合并而成。集团总部位于珀斯，在马来西亚拥有广泛业务。该公司致力于为全球市场提供一流的天然成分和健康产品。Holista是草药和成分研究的领导者，旨在为消费者提供更健康的食品。 Holista在澳大利亚证券交易所（” ASX”）上市，致力于研究、开发，制造和销售”健康型”产品，以满足针对天然药物的未被满足且不断变化的需求。Holista的配料组合包括低GI烘焙产品，低钠盐，低脂油炸食品和低热量糖，同时又不影响口味，气味和口感。Holista仍是唯一一家使用专利提取方法生产绵羊胶原蛋白的公司。更多资讯，请访问 http://www.holistaco.com 进一步咨询，请联系： 企业事务与商机 Rajen Manicka博士: rajen.m@holistaco.com 常规咨询: enquiries@holistaco.com 媒体与投资者关系咨询 WeR1 Consultants Pte Ltd E: holista@wer1.net; P: +65 67374844

鑑於對武漢冠狀病毒感染的擔憂進一步加深，馬來西亞民眾今日在當地藥店排隊等候，購買一種含有有效成分的手持式NatShield(TM)消毒液。事實證明，該成分可有效對抗170多種致命病原體，包括先前已知的冠狀病毒。 本土醫療保健企業Holista CollTech（以下簡稱Holista）表示，1月初消毒劑庫存清零後，自2020年1月29日起，60,000瓶NatShield(TM)的最初訂單中，已有5,000瓶被加急運送到包括Big Pharmacy在內的各大藥房中。下一批15,000瓶消毒液將於本週發往馬來西亞的各個藥房。 該20毫升消毒劑在馬來西亞藥房的零售價約為25馬幣。每瓶NatShield(TM)消毒劑均含有5％的Path-Away(R)。 Path-Away(R)是一種經美國食品藥品監督管理局和馬來西亞衛生部批准的植物性活性成分。它還在世界衛生組織認證的多個實驗室內接受了測試。 由美國南卡羅來納州的Global Infections Control Consultants LLC（以下簡稱GICC LLC）開發的Path-Away(R)可攻擊微生物的細胞壁，抑制其對繁殖所需氨基酸的攝取。微生物種群聚集在一起並在此過程中自我消亡。不含酒精的Path-Away(R)對人體無害，目前正用於測試其對武漢起源的新型冠狀病毒的有效性。 總部位於吉隆坡的Holista是澳大利亞的上市公司，是東盟地區Path-Away(R)的獨家分銷商。公司進口活性成分，然後在馬來西亞的幾家裝瓶廠按照嚴格標准進行灌裝。 Holista將NatShield(TM)分銷給三個藥房連鎖品牌，涵蓋全馬3,000多家藥房。 Holista首席執行官Rajen Manicka博士在八打靈再也Bigal Pharmacy的一家藥店的簡報會上說：”2020年1月29日庫存耗儘後，我們一直在晝夜不停地安排大馬的訂單。到目前為止，我們已經收到42,000瓶的確認訂單，其中到上週末已售出5,000瓶。” “為了滿足對消毒劑需求，我們打算在2月底之前將馬來西亞的出貨量從最初的60,000瓶增加到145,000瓶，並包括20毫升和30毫升兩種規格。我們還計劃在未來幾週內提供60毫升的家庭裝。除馬來西亞外，我們還收到了許多海外諮詢。公司將在未來幾週內更新有關出貨量增加的信息。”他補充道。 Big Pharmacy首席執行官Lee Meng Chuan補充說：”我們正在竭盡全力滿足所有71家門店的需求。客戶的健康和福祉是重中之重。我們將在未來幾週內與Holista緊密合作，以滿足客戶的需求。” Holista已確認參與國家貿易促進機構馬來西亞對外貿易發展局（以下簡稱 MATRADE）的一項倡議，以支持武漢冠狀病毒的受害者。該計劃被稱為”幫助武漢”行動。 Holista已捐贈10,000令吉作為初期捐款，並將進一步捐贈其NatShield(TM)消毒液銷售收入的2％。 拿督Rajen博士還宣布，Holista還將使用Path-Away(R)活性成分加速鼻香膏的開發，這種成分可降低感染風險。 Holista計劃於2020年3月之前申請自己的鼻香膏全球專利，以期在2020年第三季度前向國際消費市場投入該產品。 Path-Away(R)的成分已獲得”公認安全”（以下簡稱GRAS）的認證，美國食品藥品監督管理局（以下簡稱FDA）的批准，以及美國環境保護署（EPA）的豁免。它已在美國藥典（USP）中列出，且作為消毒液成功通過了USP-51測試。 Path-Away(R)還獲得了新西蘭食品安全局和環境保護局的批准。它已被馬來西亞衛生部批准使用，還特別提及了H1N1病毒。 Holista已獲許可在東南亞製造和分銷NatShield(TM)。 Holista CollTech Ltd簡介 HolistaCollTech Ltd（以下簡稱”Holista”）是一家以科研為重心的生物技術公司，由Holista Biotech SdnBhd與CollTech Australia Ltd.合併而成。集團總部位於珀斯，在馬來西亞擁有廣泛業務。該公司致力於為全球市場提供一流的天然成分和健康產品。 Holista是草藥和成分研究的領導者，旨在為消費者提供更健康的食品。 Holista在澳大利亞證券交易所（” ASX”）上市，致力於研究、開發，製造和銷售”健康型”產品，以滿足針對天然藥物的未被滿足且不斷變化的需求。 Holista的配料組合包括低GI烘焙產品，低鈉鹽，低脂油炸食品和低熱量糖，同時又不影響口味，氣味和口感。 Holista仍是唯一一家使用專利提取方法生產綿羊膠原蛋白的公司。更多資訊，請訪問 http://www.holistaco.com 進一步諮詢，請聯繫： 企業事務與商機 Rajen Manicka博士: rajen.m@holistaco.com 常規諮詢: enquiries@holistaco.com 媒體與投資者關係諮詢 WeR1 Consultants Pte Ltd E: holista@wer1.net; P: +65 67374844

The Hong Kong Institute of Directors (HKIoD) calls on listed company directors to faithfully discharge their duty as they tackle financial reporting tasks amidst the outbreak. On 4 February, the Securities and Futures Commission and the Stock Exchange of Hong Kong issued a Joint Statement in relation to results announcements in light of travel restrictions related to the severe respiratory disease associated with a novel infectious agent. The coronavirus outbreak will likely affect some issuers’ plan and progress in preparing financial information for their results announcements. Many of our fellow directors are facing a difficult situation. HKIoD had the opportunity…

Real estate management services group LHN Limited (“LHN”, and together with its subsidiaries, the “Group”) reported a revenue of approximately S$111.1 million for its full year ended 30 September 2019 (“FY2019”), an increase of 1.7% compared to the corresponding period last year (“FY2018”). Such increase was mainly attributed to an increase in revenue from the (i) commencement of operations of two new premises under the Residential Properties’ co-work co-live business; (ii) management of carparks under the Facilities Management Business; and (iii) Logistics Services Business. FY2019 also recorded (i) a gain on disposal from our security business; and (ii) an increase…

Hangzhou FUZAMEI has launched ’33 Charity’, a shared blockchain platform for tracing information, registration and storage. The Company has also donated RMB 40,000 and purchased RMB 60,000 in medical materials for Hubei charity organizations, responding to the present epidemic. As a blockchain innovater, FUZAMEI believes that transparent and open blockchain technology is the key to solving problems in the social trust system. Therefore, it has created shared blockchain system ’33 Charity’ Tracing Platform, to be used for information release, registration and storage. ’33 Charity’ Tracing Platform aims to coordinate various parties including charitable organizations by adopting blockchain technology to improve…

CareClix, Inc., an industry leader in telemedicine, and Trapollo, a Cox Business company and a leading provider of Connected Health Services, announced today a Teaming Agreement for strategic collaboration to integrate their unique platforms supporting remote patient monitoring (RPM) programs. Working together to meet market demand for better access to quality healthcare at lower cost – the combination of CareClix and Trapollo delivers providers and payers with a customizable, end-to-end solution that supports scaled deployments for a broad range of corporate customers and consumers. “We are proud to work with CareClix to expand our long track record of success and…

Real estate management services group LHN Limited (“LHN”, and together with its subsidiaries and associated companies, the “Group”; SGX stock code: 41O; SEHK stock code: 1730), held its Annual General Meeting on 30 January 2020 and was pleased to announce that its shareholders have approved the proposed final dividend of S$0.005 (equivalent to HK$0.029) per ordinary share for the financial year ended 30 September 2019. Such final dividend will be paid on Friday, 21 February 2020. For more information relating to the final dividend payment, please refer to the company’s announcements dated 28 November 2019 and 2 December 2019. About…

For the past 50 years, researchers at the National Institute for Materials Science (NIMS) have been conducting detailed short- and long-term testing of a wide variety of structural materials manufactured in Japan to ensure they can withstand long-term stresses. Now, NIMS scientists have reviewed this data, in the journal Science and Technology of Advanced Materials, summarizing the institute’s major findings. In 1966, NIMS’s predecessor, the National Research Institute for Metals, launched its ‘creep data sheet project’. The aim of this project was to determine the stress required to rupture heat-resistant steels and alloys in 100,000 hours (about 11.4 years) at…

In its latest development announcement, Blockpass IDN has revealed the creation of PASS Club – a first of its kind members-only club for users of the Blockpass App. Blockpass provides KYC-as-a-Service to businesses that operate in regulated industries, including crypto wallets, exchanges and financial services. From the Blockpass App, users can easily create a verified portable identity that can be used to onboard with any service in the Blockpass ecosystem. PASS Club is a members-only club for users of the Blockpass App. PASS Club members will have access to exclusive content, including webinars, events, research articles and more. Of particular…

Tianyun International Holdings Limited (“Tianyun International”, together with its subsidiaries, the “Group”) (Stock code: 6836.HK), a leading seller and manufacturer of processed fruits products in China announced that in view of the latest development of the coronavirus outbreak, the Group has already done all the epidemic prevention and control, and safety measures for its factories in the PRC. The Group has also made donations and contributed to the fight against the epidemic. As one of the leading food sellers and manufacturers in the PRC, safety has always been the top priority of the Group. The Group has paid high attention…